PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients
Mild cognitive impairment (MCI) is a clinically detectable initial stage of cognitive deterioration with a high conversion rate to dementia. There is increasing evidence that some of the cerebral alterations present in Alzheimer type dementia can be found in peripheral tissues. We have previously sh...
Main Authors: | Felipe Salech, Daniela P. Ponce, Carol D. SanMartín, Nicole K. Rogers, Carlos Chacón, Mauricio Henríquez, Maria I. Behrens |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00310/full |
Similar Items
-
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease
by: Felipe Salech, et al.
Published: (2020-08-01) -
Senescence Markers in Peripheral Blood Mononuclear Cells in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
by: Felipe Salech, et al.
Published: (2022-08-01) -
Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients
by: Carol D. SanMartín, et al.
Published: (2023-04-01) -
PARP-I and p53 expression in Sertoli cell during rat ontogenesis
by: R. Taherian, et al.
Published: (2010-01-01) -
PARP-1 Expression Influences Cancer Stem Cell Phenotype in Colorectal Cancer Depending on p53
by: Jose D. Puentes-Pardo, et al.
Published: (2023-03-01)